Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20092
20101
20111
20131
20141
20171
20183
20191
20201
20211
20223
20231
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting5
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AbbVie2
Amgen2
AstraZeneca2
Novartis Pharmaceuticals2
pharmaand GmbH2
Corcept Therapeutics1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms27
Ovarian Neoplasms23
Carcinoma, Ovarian Epithelial13
Peritoneal Neoplasms7
Neoplasms3
Recurrence2
Brenner Tumor1
Malnutrition1
Neoplasm Metastasis1
Pathologic Complete Response1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.